ArticleDiagnostic microbiology and infectious disease2013
Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists.
Article in Diagnostic microbiology and infectious disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 48 citations in OpenAlex.
- Antibiotic waste in a pediatric healthcare system: Wasting drugs that are in limited supply.Infection control and hospital epidemiology · 2024Article
- A pharmaceutical policy accident: collision of shareholder capitalism and Chinese state capitalism driving the shortage of an essential antibiotic.Journal of pharmaceutical policy and practice · 2024Article
- Detecting epinephrine auto-injector shortages in Finland 2016-2022: Log-data analysis of online information seeking.PloS one · 2024Article
- Managing Antibiotic Shortages in Inpatient Care-A Review of Recent Years in Comparison with the Hungarian Status.Antibiotics (Basel, Switzerland) · 2023Article
- National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA.BMC health services research · 2022Article
- Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries.Life (Basel, Switzerland) · 2021Review
- Shortages Without Frontiers: Antimicrobial Drug and Vaccine Shortages Impact Far Beyond the Individual!Frontiers in medicine · 2021Article
- Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals.Frontiers in medicine · 2020Article
- Availability and Use of Therapeutic Interchange Policies in Managing Antimicrobial Shortages among South African Public Sector Hospitals; Findings and Implications.Antibiotics (Basel, Switzerland) · 2019Article
- Article
- Antimicrobial Agent Shortages: The New Norm for Infectious Diseases Physicians.Open forum infectious diseases · 2018Article
- Trends in Pricing and Generic Competition Within the Oral Antibiotic Drug Market in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017Article
- Medicine shortages in Australia: causes, impact and management strategies in the community setting.International journal of clinical pharmacy · 2016Article
- Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.Open forum infectious diseases · 2015Review
- Antibacterial, antibiofilm and cytotoxic activities of Terminalia fagifolia Mart. extract and fractions.Annals of clinical microbiology and antimicrobials · 2015Article
- Developing a Method for Reporting Patient Harm Due to Antimicrobial Shortages.Infectious diseases and therapy · 2014Article
- Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers.Diagnostic microbiology and infectious disease · 2014Article
- The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Article
- Why drug shortages are an ethical issue.The Australasian medical journal · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
Antimicrobial shortages have made treating certain infections more difficult. A web-based survey asking about experience with antimicrobial drug shortages was distributed in 2011 to 1328 infectious diseases physician members of the Emerging Infectious Diseases Network of the Infectious Diseases Society of America. A majority (78%) of 627 respondents reported needing to modify antimicrobial choices because of drug shortages within the past 2 years. Antimicrobials most often reported as not available or available but in short supply were trimethoprim-sulfamethoxazole injection (by 65% of respondents), amikacin (by 58%), aztreonam (by 31%), and foscarnet (by 22%). Most respondents (55%) reporting a shortage indicated that the shortage adversely affected patient outcomes and that they were forced to use alternative and second line agents which were either less effective, more toxic, or more costly. Most (70%) indicated that they learned about the shortage from contact with the pharmacy after trying to prescribe a drug in short supply. More effective means of informing physicians about drug shortages is critical to lessen the impact on patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.